Population
Group B Coxsackieviruses (purified preparations and crude infected cell extracts) and hamster antisera
Design
Preclinical
Authors
Loading...
Supports VP1-targeted ELISA development for group B Coxsackieviruses; leaves open clinical validation from animal data.
This basic science study demonstrates that a sandwich ELISA can sensitively detect group B Coxsackieviruses and identifies VPI as the major shared antigenic determinant.
Katze et al. (1980) studied this question.